Atopic dermatitis: Therapeutic concepts evolving from new pathophysiologic insights

被引：59

作者：

Jung, Thomas ^{[1
]}

Stingl, Georg ^{[2
,3
]}

机构：

[1] Novartis Pharma Dev Immunol & Infect Dis Franchis, CH-4056 Basel, Switzerland

[2] Med Univ Vienna, Dept Dermatol, Div Immunol, Vienna, Austria

[3] Med Univ Vienna, Dept Dermatol, Div Allergy & Infect Dis, Vienna, Austria

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2008年 / 122卷 / 06期

关键词：

Atopic dermatitis; skin barrier function; innate immune system; adaptive immune system; filaggrin; T(H)2 cells; T(H)17 cells; immunotherapy; proof-of-concept trial;

D O I：

10.1016/j.jaci.2008.09.042

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Recent insights into the relevance of the epidermal barrier function and its interaction with components of the innate and adaptive immune responses in patients with atopic dermatitis (AD) give rise to a number of novel potential treatment options. In particular, the identification of loss-of-function mutations in the barrier protein filaggrin and of a diminished expression of certain antimicrobial peptides in AD skin stimulates new concepts to think beyond the T(H)1/T(H)2 paradigm. This review will focus on these most recent discoveries and will discuss new and corresponding proof-of-concept trials in patients with AD. It will further speculate on novel ways to restore the homeostasis among the 3 major components in AD skin suspected to be clinically relevant. (J Allergy Clin Immunol 2008;122:1074-81.)

引用

页码：1074 / 1081

页数：8

共 101 条

[1] Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers [J].

Aberg, Karin M. ;

Man, Mao-Qiang ;

Gallo, Richard L. ;

Ganz, Tomas ;

Crumrine, Debra ;

Brown, Barbara E. ;

Choi, Eung-Ho ;

Kim, Dong-Kun ;

Schroeder, Jens M. ;

Feingold, Kenneth R. ;

Elias, Peter M. .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2008, 128 (04) :917-925

[2] Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages [J].

Arkwright, PD ;

David, TJ .

BRITISH JOURNAL OF DERMATOLOGY, 2003, 149 (05) :1029-1034

[3] Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease [J].

Arkwright, PD ;

David, TJ .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (03) :531-534

[4] Prevention of allergic disease during childhood by allergen avoidance: The Isle of Wight prevention study [J].

Arshad, Syed Hasan ;

Bateman, Belinda ;

Sadeghnejad, Alireza ;

Gant, Carole ;

Matthews, Sharon M. .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (02) :307-313

[5] Toward a major risk factor for atopic eczema:: Meta-analysis of filaggrin polymorphism data [J].

Baurecht, Hansjoerg ;

Irvine, Alan D. ;

Novak, Natalija ;

Illig, Thomas ;

Buehler, Bettina ;

Ring, Johannes ;

Wagenpfeil, Stefan ;

Weidinger, Stephan .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (06) :1406-1412

[6] Wanted: A study with omalizumab to determine the role of IgE-mediated pathways in atopic dermatitis [J].

Beck, Lisa A. ;

Saini, Sarbjit .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2006, 55 (03) :540-541

[7] Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels [J].

Belloni, Benedetta ;

Ziai, Mahzad ;

Lim, Annick ;

Lemercier, Brigitte ;

Sbornik, Martin ;

Weidinger, Stephan ;

Andres, Christian ;

Schnopp, Christina ;

Ring, Johannes ;

Hein, Ruediger ;

Ollert, Markus ;

Mempel, Martin .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (05) :1223-1225

[8] Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis:: a randomized, double-blind, placebo-controlled trial [J].

Berth-Jones, J. ;

Arkwright, P. D. ;

Marasovic, D. ;

Savani, N. ;

Aldridge, C. R. ;

Leech, S. N. ;

Morgan, C. ;

Clark, S. M. ;

Ogilvie, S. ;

Chopra, S. ;

Harper, J. I. ;

Smith, C. H. ;

Rook, G. A. W. ;

Friedmann, P. S. .

CLINICAL AND EXPERIMENTAL ALLERGY, 2006, 36 (09) :1115-1121

[9] Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial [J].

Berth-Jones, J ;

Takwale, A ;

Tan, E ;

Barclay, G ;

Agarwal, S ;

Ahmed, I ;

Hotchkiss, K ;

Graham-Brown, RAC .

BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) :324-330

[10] Probiotics for the treatment or prevention of atopic dermatitis - A review of the evidence from randomized controlled trials [J].

Betsi, Gregoria L. ;

Papadavid, Evangelia ;

Falagas, Matthew E. .

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2008, 9 (02) :93-103

← 1 2 3 4 5 6 7 8 9 10 →